A stopgain mutation was found in BTNL9, a member of the butyrophilin family that plays a role in inflammatory bowel disease (IBD) [79, 80], and a novel frameshift mutation was found in VNN1, which affects the gut mucosal barrier [81–83]. Here, VNN1 is linked to inflammatory bowel disease.